Apply to trial NCT07717346

A few quick questions so the study team can decide if you might be a fit.

RecruitingEarly Phase 1Biological intervention

A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease

An open-label study to evaluate the safety and efficacy of KB111 in pediatric and adult subjects with Hailey-Hailey Disease

How this works

  1. Answer a few questions

    About 5 to 10 minutes. Skip-friendly where possible.

  2. We connect you with the study team

    When a site picks up your application, we introduce you to their team directly — with you on the thread.

  3. The team reaches out to schedule screening

    Usually within a few business days, via the contact you give.

We save your progress under this email and copy you when we connect you with the study team.

By continuing, you agree to our terms of service.